<DOC>
	<DOCNO>NCT02737878</DOCNO>
	<brief_summary>Dementia one press health care issue 21st century . Evidence suggest exercise enhances cognitive function healthy old adult . Most research focus aerobic training ( AT ) . Therefore , investigator aim assess individual effect AT resistance training ( RT ) , well interaction effect combine two type exercise training , cognitive function old adult mild cognitive impairment .</brief_summary>
	<brief_title>Reshaping Path Mild Cognitive Impairment Refining Exercise Prescription</brief_title>
	<detailed_description>Investigators conduct 6-month assessor-blinded randomized-controlled trial 200 community-dwelling adult mild cognitive impairment . Individuals randomize one four experimental group , receive 6 month exercise class four time per week : 1 ) combine aerobic training resistance training ; 2 ) aerobic training ; 3 ) resistance training ; 4 ) balance tone exercise . There two measurement session : baseline 6 month ( end intervention period ) .</detailed_description>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Mild Cognitive Impairment</mesh_term>
	<criteria>Communitydwelling Metro Vancouver Have subjective memory complaint , define selfreported feel memory worsen onset within last 5 year , determine interview corroborate informant Have baseline Montreal Cognitive Assessment ( MoCA ) score &lt; 26/30 MiniMental State Examination ( MMSE ) score &gt; 24 screen Read , write , speak English Not expect start stable fix dose antidementia medication ( e.g. , donepezil , galantamine , etc . ) 6month intervention period Able walk independently Must sufficient health participate exercise program Able comply schedule visit , treatment plan , trial procedure Provide personally sign date informed consent document indicate individual ( legally acceptable representative ) inform pertinent aspect trial . In addition , assent form provide baseline regular interval Engaged moderate ( e.g. , brisk walking ) physical activity &gt; 1 time per week , &gt; 60 minute per week , 3 month prior study entry Diagnosed dementia type Clinically suspect neurodegenerative disease cause mild cognitive impairment ( MCI ) Alzheimer 's Disease ( AD ) , vascular cognitive impairment ( VCI ) , ( e.g. , multiple sclerosis , Parkinson 's disease , Huntington 's disease , frontotemporal dementia ) At high risk cardiac complication exercise unable selfregulate activity understand recommend activity level ; 5 ) clinically important peripheral neuropathy severe musculoskeletal joint disease impairs mobility , determine his/her family physician Taking medication may negatively affect cognitive function , anticholinergic , include agent pronounce anticholinergic property ( e.g. , amitriptyline ) , major tranquilizer ( i.e. , typical atypical antipsychotic ) , anticonvulsant ( e.g. , gabapentin , valproic acid ) On hormone therapy ( estrogen , progesterone , testosterone ) last 24 month Planning participate , already enrol , concurrent clinical drug exercise trial</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>